Literature DB >> 14505761

An improved mouse model for endometriosis allows noninvasive assessment of lesion implantation and development.

Marylène Fortin1, Manon Lépine, Martin Pagé, Kevin Osteen, Bernard Massie, Patrice Hugo, Ann Muriel Steff.   

Abstract

OBJECTIVE: To test whether fragments of human endometrium transduced with the green fluorescent protein (GFP) cDNA and transplanted into nude mice can be noninvasively visualized.
DESIGN: A murine experimental model for human endometriosis.
SETTING: A biotechnology company. ANIMAL(S): Ovariectomized nude mice. INTERVENTION(S): Whole fragments of human endometrium were transduced in vitro by adenoviral infection with the GFP cDNA before transplantation into nude mice. Animals were noninvasively and repeatedly imaged before lesion collection. MAIN OUTCOME MEASURE(S): Fluorescence of GFP-expressing human endometrial fragments was evaluated before transplantation into animals. Development of endometriotic lesions was monitored through direct visualization of fluorescent tissue in the living animal or through conventional dissection. RESULT(S): GFP gene transfer into whole endometrial fragments can be performed, and a high proportion of cells express the reporter gene. Fluorescent endometrial fragments implant in nude mice and form endometriotic-like lesions, which can be directly visualized through the skin of living mice using a simple imaging device. CONCLUSION(S): This improved mouse model allows noninvasive and dynamic studies of lesion implantation and development to be conducted. In addition to helping better understand the pathophysiology of the disease, this model represents a valuable preclinical tool for testing the efficacy of new drugs targeting endometriosis, which should ultimately accelerate their development phase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505761     DOI: 10.1016/s0015-0282(03)00986-5

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy.

Authors:  Christian M Becker; Renee D Wright; Ronit Satchi-Fainaro; Tae Funakoshi; Judah Folkman; Andrew L Kung; Robert J D'Amato
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 2.  Relevant human tissue resources and laboratory models for use in endometriosis research.

Authors:  Erin Greaves; Hilary O D Critchley; Andrew W Horne; Philippa T K Saunders
Journal:  Acta Obstet Gynecol Scand       Date:  2017-04-05       Impact factor: 3.636

3.  Tracing location by applying Emerald luciferase in an early phase of murine endometriotic lesion formation.

Authors:  Hermawan Wibisono; Kazuomi Nakamura; Fuminori Taniguchi; Misako Seno; Kayoko Morimoto; Yuki Yoshimura; Tasuku Harada
Journal:  Exp Anim       Date:  2021-11-25

Review 4.  Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach.

Authors:  Nadja Tariverdian; Theoharis C Theoharides; Friederike Siedentopf; Gabriela Gutiérrez; Udo Jeschke; Gabriel A Rabinovich; Sandra M Blois; Petra C Arck
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 9.623

5.  A novel role of the Sp/KLF transcription factor KLF11 in arresting progression of endometriosis.

Authors:  Gaurang S Daftary; Ye Zheng; Zaid M Tabbaa; John K Schoolmeester; Ravi P Gada; Adrienne L Grzenda; Angela J Mathison; Gary L Keeney; Gwen A Lomberk; Raul Urrutia
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

6.  Bioluminescent imaging in induced mouse models of endometriosis reveals differences in four model variations.

Authors:  Ashley Dorning; Priya Dhami; Kavita Panir; Chloe Hogg; Emma Park; Gregory D Ferguson; Diane Hargrove; James Karras; Andrew W Horne; Erin Greaves
Journal:  Dis Model Mech       Date:  2021-08-31       Impact factor: 5.758

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.